Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» China Biotech In Review: Simcere Receives $503 Million Privatization Offer
China Biotech In Review: Simcere Receives $503 Million Privatization Offer
China Biotech In Review: Simcere Receives $503 Million Privatization Offer
Submitted by
admin
on March 17, 2013 - 11:45am
Source:
Seeking Alpha
News Tags:
Simcere
Shanghai Pharmaceutical
Catalent
ShangPharma
Pathwork Diagnostics
Sinovac Biotech
BravoBio
Headline:
China Biotech In Review: Simcere Receives $503 Million Privatization Offer
Do Not Allow Advertisers to Use My Personal information
